VANIPREVIR中间体结构式
|
常用名 | VANIPREVIR中间体 | 英文名 | tert-butyl ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate |
|---|---|---|---|---|
| CAS号 | 630421-48-6 | 分子量 | 330.40000 | |
| 密度 | 1.299g/cm3 | 沸点 | N/A | |
| 分子式 | C14H22N2O5S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | N-[(1r,2s)-1-[[(环丙基磺酰基)氨基]羰基]-2-乙烯环丙基]氨基甲酸1,1-二甲基乙酯 |
|---|---|
| 英文名 | 2-Methyl-2-propanyl {(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2 -vinylcyclopropyl}carbamate |
| 中文别名 | 阿那匹韦中间体1 |
| 英文别名 | 更多 |
| 密度 | 1.299g/cm3 |
|---|---|
| 分子式 | C14H22N2O5S |
| 分子量 | 330.40000 |
| 精确质量 | 330.12500 |
| PSA | 116.93000 |
| LogP | 3.18970 |
| 折射率 | 1.547 |
| 储存条件 | 2-8°C |
|
~98%
VANIPREVIR中间体 630421-48-6 |
| 文献：Scola, Paul M.; Wang, Alan Xiangdong; Good, Andrew C.; Sun, Li-Qiang; Combrink, Keith D.; Campbell, Jeffrey A.; Chen, Jie; Tu, Yong; Sin, Ny; Venables, Brian L.; Sit, Sing-Yuen; Chen, Yan; Cocuzza, Anthony; Bilder, Donna M.; D'Andrea, Stanley; Zheng, Barbara; Hewawasam, Piyasena; Ding, Min; Thuring, Jan; Li, Jianqing; Hernandez, Dennis; Yu, Fei; Falk, Paul; Zhai, Guangzhi; Sheaffer, Amy K.; Chen, Chaoqun; Lee, Min S.; Barry, Diana; Knipe, Jay O.; Li, Wenying; Han, Yong-Hae; Jenkins, Susan; Gesenberg, Christoph; Gao, Qi; Sinz, Michael W.; Santone, Kenneth S.; Zvyaga, Tatyana; Rajamani, Ramkumar; Klei, Herbert E.; Colonno, Richard J.; Grasela, Dennis M.; Hughes, Eric; Chien, Caly; Adams, Stephen; Levesque, Paul C.; Li, Danshi; Zhu, Jialong; Meanwell, Nicholas A.; McPhee, Fiona Journal of Medicinal Chemistry, 2014 , vol. 57, # 5 p. 1708 - 1729 |
|
~92%
VANIPREVIR中间体 630421-48-6 |
| 文献：Bristol-Myers Squibb Company Patent: US2008/14173 A1, 2008 ; Location in patent: Page/Page column 34 ; US 20080014173 A1 |
|
~90%
VANIPREVIR中间体 630421-48-6 |
| 文献：BRISTOL-MYERS SQUIBB COMPANY Patent: WO2008/64057 A1, 2008 ; Location in patent: Page/Page column 63 ; |
|
~%
VANIPREVIR中间体 630421-48-6 |
| 文献：TaiGen Biotechnology Co., Ltd. Patent: US2011/65737 A1, 2011 ; US 20110065737 A1 Title/Abstract Full Text Show Details TAIGEN BIOTECHNOLOGY CO., LTD.; LIU, Chen-Fu; LEE, Kuang-Yuan; CHENG, Pei-Chin; LIU, Yo-Chin; LO, Pin; TSENG, Kuo-Feng; CHEN, Chih-Ming; KING, Chi-Hsin Richard; LIN, Chu-Chung Patent: WO2011/34518 A1, 2011 ; WO 2011/034518 A1 |
|
~87%
VANIPREVIR中间体 630421-48-6 |
| 文献：Idenix Pharmaceuticals, Inc. Patent: US2009/202480 A1, 2009 ; US 20090202480 A1 |
| VANIPREVIR中间体上游产品 3 | |
|---|---|
| VANIPREVIR中间体下游产品 0 | |
| (3S)-N-BOC-3-fluoropyrrolidine |
| (3S)-3-fluoropyrrolidine-1-carboxylic acid tert-butyl ester |
| tert-butyI (3S)-3-fluoropyrrolidine-1-carboxylate |
| N-trans-BOC-(3S)-Fluoropyrrolidine |
| t-butyl (1R,2S)-1-(cyclopropylsulfonyl-carbamoyl)-2-vinylcyclopropylcarbamate |
| (S)-tert-butyl 3-fluoropyrrolidine-1-carboxylate |
| cyclopropanesulfonic acid (1-(R)-tert-butoxycarbonylamino-2-(S)-vinylcyclopropanecarbonyl)-amide |
| tert-butyl ((1R,2S)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)carbamate |
| (S)-1-Boc-3-fluoropyrrolidine |
| tert-butyl ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamate |
![(1R,2S)-REL-1-[[(1,1-二甲基乙氧基)羰基]氨基]-2-乙烯基-环丙羧酸乙酯结构式](https://www.chemsrc.com/caspic/261/259217-95-3.png)